Nordic BioSite Group (NBG) to acquire UK-based distributor Cambridge Bioscience and Research Donors, a biospecimens company, to reach the European customer base.
Cayman Chemical to partner up with Nano Imaging Services and T&T Scientific, to offer multidisciplinary lipid-based drug delivery nanoparticles.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 4036
Published Date: Apr 27, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Increasing prevalence of gastric diseases, such as gastritis, is estimated to boost the market growth.
The market size of gastrin hormone is anticipated to attain a CAGR OF 5% over the forecast period, i.e., 2023-2035.
Side effects associated with over secretion of gastric acid along with the less awareness level about gastric diseases are some of the factors that are estimated to be the growth hindering factors for the market expansion.
The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
The major players in the market are RayBiotech Life, Inc., KareBay Biochem, Inc., Cayman Chemical Company, Cambridge Bioscience Limited, CPC Scientific Inc., Abcepta, GenScript Biotech Corporation, Qingdao Echemi Technology Co., Ltd., VWR International, LLC., and other key players.
The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by salt type, packaging size, end-user, and by region.
The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.